{
"id":"mk19_bb_en_s2",
"subspecialtyId":"en",
"title":"Hyperglycemic Hyperosmolar Syndrome and Diabetic Ketoacidosis",
"jsonContent":{
"type":"section",
"id":"mk19_bb_en_s2",
"title":{
"__html":"Hyperglycemic Hyperosmolar Syndrome and Diabetic Ketoacidosis"
},
"titleNode":{
"type":"section-title",
"hlId":"0e9d91",
"children":[
"Hyperglycemic Hyperosmolar Syndrome and Diabetic Ketoacidosis"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_en_s2_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"14ed89",
"children":[
"Hyperglycemic hyperosmolar syndrome (",
{
"type":"abbreviation",
"title":"hyperglycemic hyperosmolar syndrome",
"children":[
"HHS"
]
},
") occurs with extreme hyperglycemia (>600 mg/dL) in older patients with type 2 diabetes mellitus, no or low serum levels of ketones, and a relatively normal arterial pH and bicarbonate level."
]
},
{
"type":"p",
"hlId":"de5d42",
"children":[
"The major manifestations of ",
{
"type":"abbreviation",
"title":"diabetic ketoacidosis",
"children":[
"DKA"
]
},
" are hyperglycemia, ketosis, and hypovolemia."
]
},
{
"type":"p",
"hlId":"35e44c",
"children":[
"Laboratory findings include a plasma glucose level ≥250 mg/dL, arterial blood pH ≤7.30, bicarbonate level ≤15 mEq/L, increased anion gap, and positive serum ketone levels."
]
},
{
"type":"p",
"hlId":"7d0e0a",
"children":[
"Evaluate patients with either HHS or DKA for underlying precipitants such as medication nonadherence, infection, and ",
{
"type":"abbreviation",
"title":"myocardial infarction",
"children":[
"MI"
]
},
" and confounding medications (atypical antipsychotics, glucocorticoids). Euglycemic DKA can occur in patients taking ",
{
"type":"abbreviation",
"title":"sodium-glucose transporter-2",
"children":[
"SGLT2"
]
},
" inhibitors."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_en_s2_2",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_en_s2_inline_t1"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"74e565",
"children":[
"DKA can present with abdominal pain."
]
},
" ",
{
"type":"list-item",
"hlId":"2418df",
"children":[
"Reducing the insulin infusion before complete clearing of ketones will cause a relapse of DKA."
]
},
" ",
{
"type":"list-item",
"hlId":"f43822",
"children":[
"Treatment of severe acidosis with bicarbonate is controversial, and evidence of benefit is lacking."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_en_s2_inline_t1":{
"id":"mk19_bb_en_s2_inline_t1",
"number":1,
"bookId":"en",
"title":{
"__html":"Study Table: Management of Hyperglycemic Crisis: DKA and HHS "
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"6dad39",
"children":[
"Study Table: Management of Hyperglycemic Crisis: DKA and HHS "
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c599fe",
"class":"col hd l",
"children":[
"Fluids"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd53f5",
"class":"col hd l",
"children":[
"Insulin (Regular)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3a4edc",
"class":"col hd l",
"children":[
"Potassium"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"76630e",
"class":"col hd l",
"children":[
"Correction of Acidosis"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4423f",
"class":"cell txt l",
"children":[
"Assess for volume status, then give 0.9% saline IV at 1 L/h initially in all patients and continue if patient is severely hypovolemic. Switch to 0.45% normal saline at 250-500 mL/h if corrected serum sodium level becomes normal or high."
]
},
" ",
{
"type":"p",
"hlId":"14704f",
"class":"cell txt l",
"children":[
"When plasma glucose level reaches 200 mg/dL in patients with DKA or 300 mg/dL in HHS in the setting of continued IV insulin, switch to 5% dextrose with 0.45% saline at 150-250 mL/h to avoid hypoglycemia."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"44bf9b",
"class":"cell txt l",
"children":[
"Give regular insulin, 0.1 U/kg, as an IV bolus, followed by 0.1 U/kg/h as an IV infusion."
]
},
" ",
{
"type":"p",
"hlId":"21628e",
"class":"cell txt l",
"children":[
"If plasma glucose level does not decrease by 10% in the first hour, give additional bolus of 0.14 U/kg and resume previous infusion rate."
]
},
" ",
{
"type":"p",
"hlId":"c614bb",
"class":"cell txt l",
"children":[
"When plasma glucose level reaches 200 mg/dL in DKA and 300 mg/dL in HHS, reduce insulin to 0.02-0.05 U/kg/h and maintain plasma glucose level between 150-200 mg/dL until anion gap acidosis is resolved in DKA."
]
},
" ",
{
"type":"p",
"hlId":"6cb7c3",
"class":"cell txt l",
"children":[
"Plasma glucose should be maintained between 250-300 mg/dL in HHS until patient is alert and hyperosmolar state resolves."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e75ae5",
"class":"cell txt l",
"children":[
"Assess for adequate kidney function with adequate urine output (approximately 50 mL/h)."
]
},
" ",
{
"type":"p",
"hlId":"fb893e",
"class":"cell txt l",
"children":[
"If serum potassium is <3.3 mEq/L, do not start insulin; instead, give IV potassium chloride, 20-30 mEq/h, through central line catheter until serum potassium level is >3.3 mEq/L. Then add 20-30 mEq of potassium chloride to each liter of IV fluids to keep serum potassium level in the 4-5 mEq/L range."
]
},
" ",
{
"type":"p",
"hlId":"135d4f",
"class":"cell txt l",
"children":[
"If serum potassium level is >5.2 mEq/L, do not give potassium chloride; instead, start insulin and IV fluids and check serum potassium level every 2 hours."
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"18a995",
"class":"cell txt l",
"children":[
"If pH is <6.9, consider sodium bicarbonate, 100 mEq in 400 mL of sterile water, and potassium chloride, 20 mEq, infused over 2 hours."
]
},
" ",
{
"type":"p",
"hlId":"e128a5",
"class":"cell txt l",
"children":[
"If pH is 6.9 or greater, do not give sodium bicarbonate."
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}